These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8657616)

  • 21. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C.
    Colonna M; Brooks EG; Falco M; Ferrara GB; Strominger JL
    Science; 1993 May; 260(5111):1121-4. PubMed ID: 8493555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene.
    Colonna M; Spies T; Strominger JL; Ciccone E; Moretta A; Moretta L; Pende D; Viale O
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7983-5. PubMed ID: 1518825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
    Blais ME; Dong T; Rowland-Jones S
    Immunology; 2011 May; 133(1):1-7. PubMed ID: 21355865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.
    Infantes S; Lorente E; Cragnolini JJ; Ramos M; García R; Jiménez M; Iborra S; Del Val M; López D
    Immunol Cell Biol; 2011 May; 89(4):558-65. PubMed ID: 20975736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on binding of HIV-1 p24gag peptide to HLA-Cw3+ cells.
    Kość A; Dubis J; Wojciechowska I; Maćkiewicz Z; Gorczyca W; Myc A; Kupryszewski G; Mańczak M; Myc P; Kuśnierczyk P
    Immunol Lett; 1998 Dec; 64(2-3):57-62. PubMed ID: 9870655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic vaccines. Peptides of fortune.
    Janeway C
    Nature; 1991 Oct; 353(6347):792. PubMed ID: 1944552
    [No Abstract]   [Full Text] [Related]  

  • 27. HLA-C revisited. Ten years of change.
    Falk CS; Schendel DJ
    Immunol Res; 1997; 16(2):203-14. PubMed ID: 9212365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood.
    Guillaume N; Loiseau P; Gagne K; Teissserenc HM; Cayuela JM; Henry G; Robin M; Peffault de Latour R; Gluckman E; Socié G; Retiere C; Dulphy N; Toubert A
    Haematologica; 2016 May; 101(5):e209-12. PubMed ID: 26819052
    [No Abstract]   [Full Text] [Related]  

  • 29. [Processing and T cell recognition of viral antigens].
    Hosaka Y
    Tanpakushitsu Kakusan Koso; 1992 Oct; 37(14 Suppl):2865-74. PubMed ID: 1438861
    [No Abstract]   [Full Text] [Related]  

  • 30. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.
    Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ
    J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
    Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
    Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biological role of HLA-C].
    Kuśnierczyk P
    Postepy Hig Med Dosw; 1995; 49(1):33-45. PubMed ID: 8657616
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.